REFERENCES
- Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158–2162.
- Termorshuizen F, Dekker FW, van Manen JG, Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the adequacy of Dialysis (NECOSAD)–2. J Am Soc Nephrol. 2004;15:1061–1070.
- Misra M, Vonesh E, Van Stone JC, Effect of cause and time of dropout on the residual GFR: A comparative analysis of the decline of GFR on dialysis. Kidney Int. 2001;59:754–763.
- Jansen MA, Hart AA, Korevaar JC, Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–1053.
- Suda T, Hiroshing K, Ohta T, The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant. 2000;15:396–401.
- Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69:1726–1732.
- Moist LM, Port FK, Orzol SM, Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–564.
- Canaud B, Chenine L, Leray-Moragues H, Wiesen H, Tetta C. Residual renal function and dialysis modality: Is it really beneficial to preserve residual renal function in dialysis patients? Nephrology. 2006;11:292–296.
- McKane W, Chandna SM, Tattersall JE, Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int. 2002;61:256–265.
- Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant. 2002;17:1814–1818.
- Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. Am J Med. 2004;116:263–272.
- Suzuki H, Kanno Y, Sugahara S, Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis. 2004;43:1056–1064.